Vitanza, Nicholas A.
Monje, Michelle
Article History
First Online: 10 July 2019
Compliance with Ethical Standards
:
: Nicholas A. Vitanza declares no potential conflicts of interest. Michelle Monje has a pending patent entitled “CAR T cell therapy to treat H3K27M midline gliomas.”
: This article does not contain any studies with human or animal subjects performed by any of the authors.